(Q81700911)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15862278%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

A homology model for human alpha-l-iduronidase: insights into human disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15862278%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15862278%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Brian P Rempel

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15862278%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Stephen G Withers

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15862278%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

10 February 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15862278%20AND%20SRC:MED&resulttype=core&format=json

Molecular Genetics and Metabolism

11 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15862278%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15862278%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15862278%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

28-37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15862278%20AND%20SRC:MED&resulttype=core&format=json

alpha-L-iduronidase forms semi-crystalline spherulites with amyloid-like properties

11 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

Genotype-phenotype correlations in mucopolysaccharidosis type I using enzyme kinetics, immunoquantification and in vitro turnover studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

Can mucopolysaccharidosis type I disease severity be predicted based on a patient's genotype? A comprehensive review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

Chemical chaperones--a new concept in drug research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

Role of quality control pathways in human diseases involving protein misfolding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

Mutations among Italian mucopolysaccharidosis type I patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

Mutation analysis of 19 North American mucopolysaccharidosis type I patients: identification of two additional frequent mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

Identification and characterization of 13 new mutations in mucopolysaccharidosis type I patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

Diversity of mutations and distribution of single nucleotide polymorphic alleles in the human alpha-L-iduronidase (IDUA) gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

Mutational analysis of 85 mucopolysaccharidosis type I families: frequency of known mutations, identification of 17 novel mutations and in vitro expression of missense mutations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

Mucopolysaccharidosis type I: identification of 8 novel mutations and determination of the frequency of the two common alpha-L-iduronidase mutations (W402X and Q70X) among European patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

Mucopolysaccharidosis type I: identification of 13 novel mutations of the alpha-L-iduronidase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

Mucopolysaccharidosis type I: identification of novel mutations that cause Hurler/Scheie syndrome in Chinese families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

Mucopolysaccharidosis type I: characterization of novel mutations affecting alpha-L-iduronidase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

Mucopolysaccharidosis type I: identification of common mutations that cause Hurler and Scheie syndromes in Japanese populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

Crystal structure of beta-D-xylosidase from Thermoanaerobacterium saccharolyticum, a family 39 glycoside hydrolase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

A classification of glycosyl hydrolases based on amino acid sequence similarities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

New families in the classification of glycosyl hydrolases based on amino acid sequence similarities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

Family 39 alpha-l-iduronidases and beta-D-xylosidases react through similar glycosyl-enzyme intermediates: identification of the human iduronidase nucleophile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

Active-site motifs of lysosomal acid hydrolases: invariant features of clan GH-A glycosyl hydrolases deduced from hydrophobic cluster analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

JPred: a consensus secondary structure prediction server

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

inferred from DOI database lookup

7 January 2021

based on heuristic

SWISS-MODEL: An automated protein homology-modeling server

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

Protein Modeling by E-mail

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

Deviations from standard atomic volumes as a quality measure for protein crystal structures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

Homology modeling, model and software evaluation: three related resources

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

Structure and function of fibronectin modules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

Identification of glu-277 as the catalytic nucleophile of Thermoanaerobacterium saccharolyticum beta-xylosidase using electrospray MS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

A case for reverse protonation: identification of Glu160 as an acid/base catalyst in Thermoanaerobacterium saccharolyticum beta-xylosidase and detailed kinetic analysis of a site-directed mutant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

Mechanism of Thermoanaerobacterium saccharolyticum beta-xylosidase: kinetic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

Conserved catalytic machinery and the prediction of a common fold for several families of glycosyl hydrolases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

Structural features of normal and mutant human lysosomal glycoside hydrolases deduced from bioinformatics analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

Glycosidase active site mutations in human alpha-L-iduronidase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

Dissecting the electrostatic interactions and pH-dependent activity of a family 11 glycosidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

The alpha-L-iduronidase mutations R89Q and R89W result in an attenuated mucopolysaccharidosis type I clinical presentation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

Human alpha-L-iduronidase. 1. Purification, monoclonal antibody production, native and subunit molecular mass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.006

10.1016/J.YMGME.2004.12.006

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15862278%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference